Advent Bioservices
London, United Kingdom
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
78.1
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (2)
○ EMA GMP
✓ MHRA GMP (2)
Quick Facts: Advent Bioservices
- Signal Score
- 78.1/100 (as of 2026-09-07)
- Quality Compliance
- 100.0/100
- Headquarters
- London, United Kingdom
- Modalities
- AAV, Lentiviral, Adenoviral
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Advent Bioservices
Pure-play CDMO.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
100.0
FDA InspectionsNo US records on file
MHRA GMP Certificates2 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Adenoviral
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
58.0
Profile-based capacity assessment
Recent Press2 articles
Advent Bioservices MHRA GMP Compliance 2 certificates
2025-02
2025-02
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK MIA 54923 Insp GMP 54923/21898763-0009[H] | ADVENT BIOSERVICES LTD | CAMBRIDGE CB22 3JG | 2025-02-20 | COMPLIANT |
| UK MIA(IMP) 54923 Insp IMP 54923/21898763-0010[I] | ADVENT BIOSERVICES LTD | CAMBRIDGE CB22 3JG | 2025-02-20 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Oct 06, 2026
Recent News 2 articles
Northwest Bio (OTCQB: NWBO) closes Advent BioServices related-party deal - Stock Titan
Northwest Bio (OTCQB: NWBO) closes Advent BioServices related-party deal Stock Titan
Northwest Biotherapeutics completes acquisition of Advent BioServices - Investing.com
Northwest Biotherapeutics completes acquisition of Advent BioServices Investing.com
Frequently Asked Questions About Advent Bioservices
Does Advent Bioservices hold EMA or MHRA GMP certificates?
CDMO Signal tracks 2 MHRA GMP certificates for Advent Bioservices.
What is Advent Bioservices's CDMO Signal Score?
Advent Bioservices has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating Advent Bioservices for a manufacturing program?
Use the free AI matchmaker to compare Advent Bioservices against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 81.0
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid
SK pharmteco
Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Signal Score: 79.5
Viral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
Exothera
Jumet, BE
Signal Score: 78.1
AAV, Adenoviral, Lentiviral
Vigene Biosciences
Rockville, MD
Signal Score: 72.5
AAV, Lentiviral, Adenoviral
Ascend Advanced Therapies
London, United Kingdom
Signal Score: 78.1
AAV, Lentiviral, Plasmid